“Challenges in managing lisdexamfetamine dimesylate in the treatment of Attention Deficit Hyperactivity Disorder”, Acervo Saúde, vol. 24, no. 12, p. e17434, Dec. 2024, doi: 10.25248/reas.e17434.2024.